Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome

Table 4

Details of recurrent strokes.

Age at recurrent stroke	Delay	Type of stroke	Cause identified	Prosthesis type	ATT at time of event	TEE shunt/thrombus	Atrial fibrillation	Outcome
56 years	4 years	Ischemic	No	Cardia	Aspirin	No/No	No	Recovery
43 years	1.1 year	Ischemic	No	Cardia	Aspirin	Yes/No	No	Recovery
52 years	4.4 years	Ischemic	Carotid occlusion	Cardia	Anticoagulant	Not evaluated	No	Death
58 years	1.4 year	Ischemic	No	Amplatzer	None	No/No	No	Recovery
30 years	0.8 year	Ischemic	PFO device thrombosis	Occlutech	None	No/Yes	No	Persistant illness
43 years	0.5 year	Ischemic	Atrial fibrillation	Occlutech	Aspirin	No/No	Yes	Recovery
21 years	0.2 year	Ischemic	No	Cardia	Aspirin	No/No	No	Recovery

ATT = antithrombotic therapy; PFO = patent foramen ovale; TEE = transesophageal echocardiography.